This Letter describes the synthesis, representative structure activity relationship (SAR), activity and PK profiles of a series of functionalized benzimidazole-naphthylene-imidazole derivatives as HCV NS5A inhibitors. This effort successfully led to the discovery of ravidasvir (PPI-668), which has been well tolerated and shown high sustained viral response rates as a key component in all-oral combination regimens in multiple human clinical trials.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2016.07.066 | DOI Listing |
Publication Analysis
Top Keywords
discovery ravidasvir
8
ravidasvir ppi-668
8
hcv ns5a
8
ppi-668 potent
4
potent pan-genotypic
4
pan-genotypic hcv
4
ns5a inhibitor
4
inhibitor letter
4
letter describes
4
describes synthesis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!